What's new

Human medicines European public assessment report (EPAR): Soliris, eculizumab, Date of authorisation: 20/06/2007, Revision: 38, Status: Authorised

Human medicines European public assessment report (EPAR): Soliris, eculizumab, Date of authorisation: 20/06/2007, Revision: 38, Status: Authorised

Feb 27, 2025 - 10:44
 0
Human medicines European public assessment report (EPAR): Soliris, eculizumab, Date of authorisation: 20/06/2007, Revision: 38, Status: Authorised
Human medicines European public assessment report (EPAR): Soliris, eculizumab, Date of authorisation: 20/06/2007, Revision: 38, Status: Authorised
Read More

Tags:

Previous Article

Kia EV4, PV5 and Concept EV2 make debuts at 2025 Kia EV Day as embodiment of exp...

Next Article

LVMH spotlights staff in new campaign

Related Posts

PSUSA/00010605/202407

PSUSA/00010605/202407

Feb 13, 2025  0

Human medicines European public assessment report (EPAR): Yondelis, trabectedin, Date of authorisation: 17/09/2007, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 3, 2025  0

PSUSA/00010774/202403

PSUSA/00010774/202403

Feb 9, 2025  0